Prognostic Value of Magnetic Resonance Imaging for Assessment of Structural Heart Disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037831

Enrollment

5000

Registered

2026-03-23

Start date

2026-02-11

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

structural heart disease

Interventions

Group 1: all patients undergoing cardiac MRI

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: clinically indicated heart MRT

Exclusion criteria

Exclusion criteria: contraindication for MRT or gadolinium

Design outcomes

Primary

Measure	Time frame
sudden cardiac death, successful reanimation, adequate ICD therapy	—

Secondary

Measure	Time frame
composites of primary endpoint, total mortality, myocardial infarction, heart transplantation, hospitalization for heart failure, NYHA stage at follow up.	—

Countries

Germany

Contacts

Public ContactMartin Hadamitzky

TUM-Klinikum Deutsches Herzzentrum, Institut für kardiovaskuläre Radiologie und Nuklearmedizin

mhy@dhm.mhn.de+49-89-1218-4511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026